Company Bionik Laboratories Corp OTC Bulletin Board
Equities
US09074A1097
Medical Equipment, Supplies & Distribution
End-of-day quote
Other stock markets
|
||
- USD | - |
2023 | Bionik Laboratories Corp. Announces Executive Changes | CI |
2023 | Bionik Laboratories Corp. Reports Earnings Results for the Full Year Ended March 31, 2023 | CI |
Business Summary
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Rehabilitation Products
66.2
%
| 1 | 68.3 % | 1 | 66.2 % | +37.27% |
Service, Extended Warranty & Other
19.7
%
| 0 | 14.2 % | 0 | 19.7 % | +96.22% |
Subscriptions
14.1
%
| 0 | 17.4 % | 0 | 14.1 % | +14.74% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Canada
100.0
%
| 1 | 100.0 % | 2 | 100.0 % | +41.73% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Richard Russo
CEO | Chief Executive Officer | 44 | 20-11-29 |
Michal Prywata
FOU | Founder | 33 | 10-01-07 |
Dan Gonsalves
DFI | Director of Finance/CFO | - | 21-08-31 |
John Smathers
COO | Chief Operating Officer | - | - |
Mark Eiseman
SAM | Sales & Marketing | - | 21-12-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Michal Prywata
FOU | Founder | 33 | 10-01-07 |
Director/Board Member | 68 | 17-08-31 | |
Richard Russo
CEO | Chief Executive Officer | 44 | 20-11-29 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 12,480,431 | 2,495,606 ( 20.00 %) | 0 | 20.00 % |
Company contact information
Bionik Laboratories Corp.
80 Coolidge Hill Road
02472, Watertown
+877-379-9283
http://www.bioniklabs.comSector
Sales per Business
1st Jan change | Capi. | |
---|---|---|
-7.16% | 177B | |
-4.86% | 65.54B | |
-4.28% | 47.09B | |
+10.32% | 43.43B | |
+8.14% | 41.77B | |
+15.76% | 29.55B | |
+15.53% | 24.83B | |
-5.88% | 23.97B | |
-5.38% | 23.54B |
- Stock Market
- Equities
- BNKL Stock
- Stock
- Company Bionik Laboratories Corp